drugset
Drugs / SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
last change Dec 2022 re-read 3 minutes ago

SARS-CoV-2 Vaccine, Inactivated (Vero Cell)

Vaccine

Developed for
COVID-19
Investigated by
Chinese Academy of Medical Sciences · Yunnan Center for Disease Control and Prevention · Hubei Provincial Center for Disease Control and Prevention

Trials 3

today NCT05216484 · Ph 3 NCT05163652 · Ph 3 NCT05164731 · Ph 3
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05216484 Feb → Oct 2022 COVID-19 Chinese Academy of Medical Sciences Unknown No outcome recorded
Phase 3 NCT05163652 Dec 2021 → Aug 2022 COVID-19 Chinese Academy of Medical Sciences Unknown No outcome recorded
Phase 3 NCT05164731 Dec 2021 → Aug 2022 COVID-19 Chinese Academy of Medical Sciences Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as SARS-CoV-2 Vaccine, Inactivated (Vero Cell) ClinicalTrials.gov intervention name — accepted as the source's own label NCT05164731 ↗
2

NCT05216484 ↗

NCT05163652 ↗
Modality Vaccine “SARS-CoV-2 Vaccine, Inactivated (Vero Cell)” NCT05163652 ↗